Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 54, 6383-6386, December 15, 1994]
© 1994 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brauer, M.
Right arrow Articles by Thompson, R. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brauer, M.
Right arrow Articles by Thompson, R. T.

Insulin Protects against Hepatic Bioenergetic Deterioration Induced by Cancer Cachexia: An in Vivo 31P Magnetic Resonance Spectroscopy Study

Manfred Brauer, Richard I. Inculet1, Gopal Bhatnagar, Gregory D. Marsh, Albert A. Driedger and R. Terry Thompson

Department of Chemistry and Biochemistry, University of Guelph, Guelph, Ontario, Canada N1G 2W1 [M. B.], and Department of Surgery and Nuclear Medicine, Victoria Hospital [R. I. I., G. B., A. A. D.], and Department of Nuclear Medicine and Magnetic Resonance, Lawson Research Institute, St. Joseph's Health Care Centre, The University of Western Ontario [G. D. M., R. T. T.], London, Ontario, Canada N6G 3V4

The bioenergetic effects of cancer cachexia on the livers of male Fischer rats inoculated with a methylcholanthrene-induced sarcoma were assessed using serial in vivo 31P magnetic resonance spectroscopy. Rats were randomized into three groups: tumor-bearing controls (n = 7); an insulin-treated group receiving 2 units/100 g body weight/day starting 21 days after implantation (n = 8); and a chronic insulin-treated group receiving insulin every day after implantation (n = 3). During the 32-day study, serial measurements of food intake, body weight, and tumor volume were taken, and 31P magnetic resonance spectroscopy analyses of the livers were conducted every 7 days after tumor implantation. Neither the short-term nor the chronic insulin treatment regimens stimulated the progress of tumor growth. However, both treatments prevented body weight loss, and the short-term insulin treatment prevented tumor-induced decrease in food intake relative to the control group. Liver bioenergetic deterioration was evaluated from the increase in the ratio of P1 to ATP obtained from the hepatic 31P magnetic resonance spectra. At day 28 postimplantation, control rats exhibited appreciable hepatic bioenergetic deterioration, i.e., a Pi/ATP ratio of 1.41 ± 0.35 (SE), significantly higher (P < 0.05) than the Pi/ATP ratio for short-term or chronic insulin treatment groups (Pi/ATP 0.92 ± 0.22 and 0.84 ± 0.22, respectively) or rats before tumor implantation (Pi/ATP 0.76 ± 0.14). This insulin-induced bioenergetic protection occurred at any given tumor burden up to at least 10%. Thus, both short-term insulin given just prior to the frank manifestations of cancer cachexia and chronic insulin treatment given throughout tumor growth ameliorated host hepatic bioenergetic deterioration without significantly stimulating tumor growth. Insulin may act by altering the host metabolism (stimulation of liver glucose uptake and utilization, decreased energy-requiring gluconeogenesis, and general protein-sparing action) at the expense of the tumor.

1 To whom requests for reprints should be addressed, at Department of Surgery, Victoria Hospital, 375 South Street, London, Ontario, Canada N6G 3V4.

Received 6/ 2/94. Accepted 10/12/94.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
K. Lundholm, U. Korner, L. Gunnebo, P. Sixt-Ammilon, M. Fouladiun, P. Daneryd, and I. Bosaeus
Insulin Treatment in Cancer Cachexia: Effects on Survival, Metabolism, and Physical Functioning
Clin. Cancer Res., May 1, 2007; 13(9): 2699 - 2706.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Leij-Halfwerk, J. W. O. van den Berg, P. E. Sijens, J. H. P. Wilson, M. Oudkerk, and P. C. Dagnelie
Altered Hepatic Gluconeogenesis during L-Alanine Infusion in Weight-losing Lung Cancer Patients as Observed by Phosphorus Magnetic Resonance Spectroscopy and Turnover Measurements
Cancer Res., February 1, 2000; 60(3): 618 - 623.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
A. Inui
Cancer Anorexia-Cachexia Syndrome: Are Neuropeptides the Key?
Cancer Res., September 1, 1999; 59(18): 4493 - 4501.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1994 by the American Association for Cancer Research.